Government ❯ Regulations

FDA

Drug Approval Drug Approval Process Food Safety Standards Drug Safety Food Safety Food Labeling Recalls Recall Abortion Pill USDA FDA Regulations Medical Device Approval Manufacturing Practices Medical Devices Food Safety Regulations Food Regulations Gene Therapy Drug Inspections Unapproved Animal Antibiotics Unapproved Animal Drugs Recall Notice Recall Process Recall notice Consent Decree Certification Drug Labeling Pharmacy Certification Approval Process Alerts FDA Approval Mifepristone Abortion Access Biden Administration Drug Approval Protocol Supreme Court FDA Recall CDC Approval Federal Restrictions Warnings Class I Recall Modernization Acts Manufacturing Standards Labeling Changes Guidelines OTC Products Sunscreen Approval Process Abortion Policies Human Trials Voluntary Recall Product Recalls Advisory Panels E-cigarettes Legal Standing THC Products Proposition 65 Tobacco Regulations Medical Device Safety E-cigarette Manufacturers Inspection Ban on Juul E-Cigarette Products Tobacco Products Gene Editing

Louisiana’s Challenge to FDA’s Mifepristone Mail-Order Rule Heard in Federal Court

The Justice Department is urging the court to pause the case during the FDA’s renewed safety review of mifepristone.

FDA Issues Draft Guidance Easing Primate Tests for Some Antibody Drugs

Missouri, Kansas and Idaho Sue to Block FDA’s New Generic Mifepristone Approval, Curb Mail-Order Access

FDA Adds Boxed Warning to Elevidys, Narrows Use to Ambulatory Patients 4 and Older

Kenvue Asks FDA to Reject Autism Warning on Tylenol in Pregnancy

FDA Rejects Replimune’s RP1 Melanoma Immunotherapy

FDA and A.P. Deauville Recall Over 67,000 Cases of Power Stick Roll-On Deodorant

FDA and A. P. Deauville Recall Over 67,000 Power Stick Roll-On Deodorants

FDA Approves Gardenia Blue, Urges Accelerated Red No. 3 Phase-Out

FDA Ends GLP-1 Drug Shortages, Triggering New Pricing and Coverage Moves